$233.80
Price
$12.0B
Market Cap
—
P/E Ratio
39.4
Forward P/E
$-3.72
EPS (TTM)
—
Dividend Yield
$305M
Cash
$218M
Total Debt
51M
Shares Out
$96.09
$260.19
52-Week Range
Institutional Ownership of Axsome Therapeutics
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for Axsome Therapeutics
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | +2.1% | 17.4K | $2M | $111.70 | |
| SELL | EXIT | — | — | $111.70 | |
| 2025-Q2 | |||||
| SELL | -0.3% | 17.1K | $2M | $105.41 | |
| BUY | NEW | 3.2K | $337388 | $105.41 | |
| 2025-Q1 | |||||
| SELL | -0.3% | 17.1K | $2M | $119.50 | |
| 2024-Q4 | |||||
| BUY | +45.3% | 17.2K | $1M | $90.97 | |
| 2024-Q3 | |||||
| BUY | +0.7% | 11.8K | $1M | $86.17 | |
| 2024-Q2 | |||||
| BUY | +11.5% | 11.7K | $945634 | $74.18 | |
| 2024-Q1 | |||||
| BUY | NEW | 10.5K | $840932 | $82.95 | |
Insider Trading for Axsome Therapeutics
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.